The first of our three core missions is to:



Esophageal cancer (adenocarcinoma) is considered the fastest growing cancer in the Untied States.  In the past four decades, esophageal cancer has increased 733%.

Esophageal cancer is also one of the deadliest cancers as survival rates of esophageal cancer are extremely low. Patients diagnosed with Stage IV face a daunting survival rate of only 4.8%.  Unfortunately, the overall 5 year survival rate is 19.2%.

There are better treatment options for early esophageal cancer diagnosis.  Advanced esophageal cancer is difficult, if not almost impossible, to cure and treatments are usually directed towards relieving cancer symptoms in attempts to improve the quality of life.

There are no standard or routine screenings to detect esophageal cancer in the earlier stages, when the tumors can be treated.  Symptoms such as difficulty swallowing (dysphagia) typically do not arise until the cancer has become advanced.

The Salgi Esophageal Cancer Research Foundation strongly believes that educating the public regarding prevention methods and the risk factors associated with esophageal cancer will tremendously help to reduce the amount of esophageal cancer diagnosis and deaths.

In order to save lives, we must encourage patients to speak with their doctors regarding lifestyle changes to help lower their risk of developing esophageal cancer.

For those patients with a higher risk of developing esophageal cancer, we wish to empower them to insist on early screening tests which can help save their lives.  Read more about our next core mission “Encourage Early Detection” by clicking here.

Support awareness efforts for esophageal cancer by making a one-time or recurring, tax-deductible donation.





Esophageal Cancer Sees Dramatic Spike.” Gastroenterology and Endoscopy News
Management of Barrett’s oesophagus and intramucosal oesophageal cancer: a review of recent development. Shanmugarajah Rajendra and Prateek Sharma, Copyright, 2012, National Center for Biotechnology Information, U.S. National Library of Medicine. Bethesda MD,
SEER Cancer Statistics Factsheets: Esophageal Cancer. National Cancer Institute. Bethesda, MD,
Survival rates for cancer of the esophagus by stage. 2014, American Cancer Society, Atlanta, GA,
Barrett’s esophagus and esophageal adenocarcinoma in adults: long-term GERD or something else? Pondugula K, Wani S, Sharma P, Copyright, 2007 National Center for Biotechnology Information, U.S. National Library of Medicine. Bethesda, MD,
A Snapshot of Esophageal Cancer Trends in NCI Funding for Esophageal Cancer Research. 2013, National Cancer Institute, Bethesda, MD,
Non-Invasive Detection of Esophageal Cancer using Genetic Changes in Circulating Cell-Free DNA Avicenna Journal of Medical Biotechnology, Vol. 4, No. 1, January-March 2012

Comments are closed.

%d bloggers like this: